PROVIDER PROFILE · NPI 1245341544

Camila Manrique AcevedoM.D.

PRACTICEMED-TRANS CORPORATIONSee all providers at this practice →

EndocrinologyColumbia, MOI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$2K

Peer benchmark

Total Medicare services vs. 144 Endocrinology providers in MO — bottom quintile (cohort median 929).

PRESCRIBING · PART D · 2024

Total Rx claims

202

Beneficiaries

—

Total drug cost

$35K

Distinct drugs

Brand share

37.1%

Top prescribed drugs

Levothyroxine Sodium102 claims

Alendronate Sodium25 claims

Empagliflozin16 claims

Semaglutide16 claims

Levothyroxine Sodium16 claims

QUALITY · MIPS · 2024

Final MIPS score

80.2

Quality

58.2

Cost

75.9

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.22%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$110

Payment records

By payment type

Food and Beverage$110

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 260141

Hospital

REFERRAL NETWORK

Where Camila Manrique Acevedo's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
BOYCE - BYNUM PATHOLOGY LABORATORIES, INC	15	55

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
CURATORS OF THE UNIVERSITY OF MISSOURI	148	827
Mary Dohrmann Cardiology · Columbia, MO	14	28
Robert Zitsch Otolaryngology · Columbia, MO	12	41

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history